The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during setup, they noticed the temperature probes did not function.As per sales associate, the product wasn't changed out, to mitigate the problem, the customer monitored the venous temperature on the recirculation line.No known impact or consequence to patient.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on january 26, 2021.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 11, 3331, 4114, 3221, 4315).Type of investigation code #!: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation code #2: 3331 - analysis of production records.Type of investigation code #3: 4114 - device not returned.Investigation findings: 3221 - no findings available.Investigation conclusions: 4315 - cause not established.The affected sample was returned for evaluation so a thorough investigation could not be performed.Representative retentions samples from the potentially affected lot numbers were reviewed with no damage noted to the arterial thermistor.Additionally, the thermistors were checked to confirm continuity within the thermistor.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|